AdvaMed and Georgia Bio Send Letter to Natural Resources & Environment Committee Related to Ethylene Oxide

On behalf of the Advanced Medical Technology Association (AdvaMed) and Georgia Bio, we wrote to the Natural Resources & Environment Committee to share our comments on Senate Bill 426, being considered by the legislature, related to ethylene oxide. As you may know, billions of medical devices each year in the U.S. are sterilized using ethylene oxide. The direct impact of severe restriction on the ability to sterilize medical devices could compromise the medical device industry’s ability to provide a consistent, stable, and safe supply of medical supplies to patients nationwide during the COVID-19 pandemic.

As the threat of antimicrobial resistance to disease-causing, mutating microbes continues to rise in the U.S. and around the globe, now more than ever, we need to ensure the medical and surgical equipment health care providers use is sterile. Ethylene oxide allows sterile surgeries to happen.

Please click here to view the full letter to the committee.

Life Sciences Industry Partners Host Interns from Athens Community Career Academy Biomanufacturing Program.

June 1, 2026
Athens Bioscience, Inc. worked with an intern from the Biomanufacturing Program at ACCA developed by partnerships including local industry, county and State officials, educators, and Georgia Life Sciences. “We’ve got many large (biomanufacturing) corporations here in (Athens-Clarke) County,” ACCA Biotechnology Instructor Stan Harrison said. “They need skilled workers and they need them from all walks (of life).” As the program matures, students engage in internships at local industry sites to learn real-world applications for what they have learned through the Biomanufacturing pathway. Learning outcomes include not only the traditional biotechnology framework, but also automation and engineering fundamentals crucial in today’s biomanufacturing settings.

Reps. McCormick, Khanna Introduce a Bipartisan Package to Close America's Biotechnology Workforce Gap

May 29, 2026
Biotechnology Workforce Alignment Act of 2026 pairs with a companion bill to assess and strengthen the federal biotech pipeline.

Georgia Strengthens Life Sciences Workforce Pipeline with Continued Investment in Biotech Education

May 29, 2026
May 29, 2026 - Georgia Life Sciences is grateful to Governor Brian Kemp and the Georgia General Assembly for their continued investment in innovation, workforce development, and the future of Georgia’s life sciences ecosystem through the FY27 state budget. This funding, now in its 8th year, will support the continued growth of Georgia Life Sciences’ Biotech Teacher Training Initiative (BTTI) and strengthen our mission to build a world-class life sciences workforce pipeline across the state. By equipping educators with hands-on biotechnology and medtech training, industry-aligned curriculum (integrating medtech/AI/robotics), and real-world learning experiences, we are helping prepare students for high-demand careers in Georgia’s rapidly growing life sciences sector. Georgia continues to demonstrate national leadership by investing in the infrastructure, talent, and partnerships needed to drive scientific innovation, economic growth, and improved health outcomes. We appreciate the support of Governor Kemp and members of the General Assembly who recognize the critical role the life sciences industry plays in Georgia’s economy and future competitiveness.
MORE POSTS